Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 286 AL 300

Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease

Shoaib M, Kamal MA, Rizvi SMD.

Curr Drug Metab. 2017;18(9):842-852. doi: 10.2174/1389200218666170607101622.

Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease

Nesi G, Sestito S, Digiacomo M, Rapposelli S.

Curr Top Med Chem. 2017;17(27):3062-3079. doi: 10.2174/1568026617666170607114232.

A systematic review and meta-analysis of the circulatory, erythrocellular and CSF selenium levels in Alzheimer's disease: A metal meta-analysis (AMMA study-I)

Reddy VS, Bukke S, Dutt N, Rana P, Pandey AK.

J Trace Elem Med Biol. 2017 Jul;42:68-75. doi: 10.1016/j.jtemb.2017.04.005. Epub 2017 Apr 23.

The amyloid beta-precursor protein-The unappreciated cerebral anticoagulant

Schmaier AH.

Thromb Res. 2017 Jul;155:149-151. doi: 10.1016/j.thromres.2017.05.037. Epub 2017 Jun 2.

Performance comparison of 10 different classification techniques in segmenting white matter hyperintensities in aging

Dadar M, Maranzano J, Misquitta K, Anor CJ, Fonov VS, Tartaglia MC, Carmichael OT, Decarli C, Collins DL; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2017 Aug 15;157:233-249. doi: 10.1016/j.neuroimage.2017.06.009. Epub 2017 Jul 3.

Brain Amyloid Pathology and Cognitive Function: Alzheimer Disease Without Dementia?

Visser PJ, Tijms B.

JAMA. 2017 Jun 13;317(22):2285-2287. doi: 10.1001/jama.2017.6895.

Stem cell models of Alzheimer's disease: progress and challenges

Arber C, Lovejoy C, Wray S.

Alzheimers Res Ther. 2017 Jun 13;9(1):42. doi: 10.1186/s13195-017-0268-4.

Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse"

Thambisetty M.

Am J Physiol Cell Physiol. 2017 Oct 1;313(4):C353-C361. doi: 10.1152/ajpcell.00111.2017. Epub 2017 Jun 14.

Spreading of Pathology in Alzheimer's Disease

Lv ZY, Tan CC, Yu JT, Tan L.

Neurotox Res. 2017 Nov;32(4):707-722. doi: 10.1007/s12640-017-9765-2. Epub 2017 Jun 16.

Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study

Törmälehto S, Martikainen J, Bell JS, Hallikainen I, Koivisto AM.

Int Psychogeriatr. 2017 Oct;29(10):1723-1733. doi: 10.1017/S1041610217001090. Epub 2017 Jun 19.

Synaptic dysfunction in Alzheimer's disease: From the role of amyloid β-peptide to the α-secretase ADAM10

Musardo S, Marcello E.

Eur J Pharmacol. 2017 Dec 15;817:30-37. doi: 10.1016/j.ejphar.2017.06.018. Epub 2017 Jun 16.

The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology

Canu N, Amadoro G, Triaca V, Latina V, Sposato V, Corsetti V, Severini C, Ciotti MT, Calissano P.

Int J Mol Sci. 2017 Jun 20;18(6):1319. doi: 10.3390/ijms18061319.

Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery

Uliassi E, Gandini A, Perone RC, Bolognesi ML.

Future Med Chem. 2017 Jun;9(10):995-1013. doi: 10.4155/fmc-2017-0038. Epub 2017 Jun 20.

Targeting psychologic stress signaling pathways in Alzheimer's disease

Futch HS, Croft CL, Truong VQ, Krause EG, Golde TE.

Mol Neurodegener. 2017 Jun 21;12(1):49. doi: 10.1186/s13024-017-0190-z.

Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease

Annadurai N, Agrawal K, Džubák P, Hajdúch M, Das V.

Cell Mol Life Sci. 2017 Nov;74(22):4159-4169. doi: 10.1007/s00018-017-2574-1. Epub 2017 Jun 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias